Economic Burden of Knee Osteoarthritis in Talavera de la Reina Health Area.
1 other identifier
observational
400
1 country
1
Brief Summary
This is a descriptive retrospective study of individuals affected with knee osteoarthritis. The aim of this study is to describe the sociodemographic and clinical characteristics of individuals diagnosed with knee osteoarthritis within a specific health area, as well as to assess the economic impact of this condition on the healthcare system. To achieve this, medical records will be reviewed, and the following data will be collected: Sociodemographic and clinical participant data. Healthcare resource use. Clinical burden. Up to 400 subjects will be enrolled in the Talavera de la Reina Health Area (Toledo, Spain).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2023
CompletedFirst Submitted
Initial submission to the registry
November 27, 2023
CompletedFirst Posted
Study publicly available on registry
December 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2024
CompletedDecember 6, 2023
November 1, 2023
9 months
November 27, 2023
November 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Healthcare resource use
Healthcare resource use will be collected from medical records. The data will be collected by four collaborators from the healthcare system, filling out electronic forms on REDCap. The health direct cost will be the following: The number of visits in primary and specialized care and type of health professional, number and type of surgical interventions, and number of emergencies at both health centers and hospitals. Type and number of diagnostic tests. Pharmacotherapy (type of drug and dose). The number of sessions of physical therapy.
Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
Participants sociodemographic characteristics
Age, weight, height and work activity.
Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
Participant clinical characteristics
Severity of knee osteoarthritis with the radiographic Kellgren and Lawrence classification. Disease progression time.
Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
Secondary Outcomes (3)
Charlson Comorbidity Index (CCI)
Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
Work absences
Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
Physical therapy treatment
Data will be collected from from the initial radiologic diagnosis registered in the electronic database to December 31, 2019.
Study Arms (1)
Knee osteoarthritis participants
Participants who are registered in the Health system electronic database, with a clinical and radiographic diagnostic of knee osteoarthritis. Approximately a total of 400 participants will be enrolled in the study.
Interventions
Data related to the knee osteoarthritis will be extracted from patients' medical records: The sociodemographic and clinical participants' characteristics: age, weight, height, duration of the condition, and occupational activity. The healthcare costs: the number of visits in primary and specialized care, diagnostic tests, surgical interventions, and emergencies at both health centers and hospitals, physical rehabilitation and number of sessions. Charlson Comorbidity Index (CCI). Pharmacotherapy (type of drug and dose). Work absences (temporary and permanent).
Eligibility Criteria
Individuals with a diagnosis of knee osteoarthritis registered in the electronic database of Talavera de la Reina Health Area, Toledo, Spain.
You may qualify if:
- Patients ≥18 years old.
- Diagnosed with unilateral or bilateral knee osteoarthritis according to the clinical criteria of the American College of Rheumatology.
- Radiographic imaging diagnosis based on the Kellgren \& Lawrence (K-L) classification.
You may not qualify if:
- No available X-ray.
- Pre-existing neurological diseases before the diagnostic date (stroke, Parkinson's, multiple sclerosis, ALS).
- Connective tissue disorders (Ehlers-Danlos, Marfan). Secondary cause of osteoarthritis or severe osteoarthritis (ACL tears, severe traumas, infections, or sepsis).
- Inflammatory arthropathy (any type of arthritis).
- Genetic disorders with a higher risk of developing arthropathies (Down syndrome).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Nuestra Señora del Prado
Talavera de la Reina, Toledo, 45600, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
November 27, 2023
First Posted
December 6, 2023
Study Start
April 1, 2023
Primary Completion
December 31, 2023
Study Completion
January 31, 2024
Last Updated
December 6, 2023
Record last verified: 2023-11